Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-21-000600
Filing Date
2021-04-09
Accepted
2021-04-09 16:07:37
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LPCORMORANT PRIVATE HEALTHCARE FUND II, LPCORMORANT PRIVATE HEALTHCARE FUND III, LPCORMORANT PRIVATE HEALTHCARE GP II, LLCCORMORANT PRIVATE HEALTHCARE GP III, LLC

Document Format Files

Seq Description Document Type Size
1 schedule13g.htm SC 13G 152462
2 JOINT FILING AGREEMENT exhibit99-1.htm EX-99.1 13692
  Complete submission text file 0000929638-21-000600.txt   168122
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 991C LOMAS SANTA FE #436 SOLANA BEACH CA 92121
Business Address 991C LOMAS SANTA FE #436 SOLANA BEACH CA 92121 858-293-4900
Design Therapeutics, Inc. (Subject) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92462 | Film No.: 21817897
SIC: 2834 Pharmaceutical Preparations